The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy
<b>Background:</b> Respiratory syncytial virus (RSV) is a common cause of acute respiratory infection (ARI). The risk of severe RSV outcomes is higher among older adults (OAs) and individuals with chronic diseases (high risk, HR). AS01<sub>E</sub>-adjuvanted RSV preFusion pro...
Saved in:
| Main Authors: | Anna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, Alen Marijam, Giovanna Elisa Calabró |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/3/212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany
by: Maria Waize, et al.
Published: (2025-12-01) -
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort study
by: Anna Puggina, et al.
Published: (2025-12-01) -
Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United States
by: Ahuva Averin, et al.
Published: (2025-12-01) -
Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis
by: Tiantian Zhang, et al.
Published: (2025-08-01) -
Healthcare Resource Utilization and Economic Outcomes of RSV-Hospitalized Patients Aged ≥ 60 Years: A Retrospective Cohort Study
by: Anna Puggina, et al.
Published: (2025-02-01)